In a general sense I think it would improve sales. Whilst it does not outline BIS is "the" solution for monitoring, in my opinion it suggests it is preferred if available. This premise in conjunction with the fact that they can make money whilst improving medical outcomes should support sales. The real question for me is what level of benefit they see vs the effort to integrate BIS into a medical system and patient management procedures.
Ann: New Clinical Practice Guidance Recommends Use of BIS, page-23
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
